Literature DB >> 22682085

The evolutionary benefit of insulin resistance.

Maarten R Soeters1, Peter B Soeters.   

Abstract

Insulin resistance is perceived as deleterious, associated with conditions as the metabolic syndrome, type 2 diabetes mellitus and critical illness. However, insulin resistance is evolutionarily well preserved and its persistence suggests that it benefits survival. Insulin resistance is important in various states such as starvation, immune activation, growth and cancer, to spare glucose for different biosynthetic purposes such as the production of NADPH, nucleotides in the pentose phosphate pathway and oxaloacetate for anaplerosis. In these conditions, total glucose oxidation by the tricarboxylic acid cycle is actually low and energy demands are largely met by fatty acid and ketone body oxidation. This beneficial role of insulin resistance has consequences for treatment and research. Insulin resistance should be investigated at the cellular, tissue and whole organism level. The metabolic pathways discussed here, should be integrated in the accepted and valid mechanistic events of insulin resistance before interfering with them to promote insulin sensitivity at any cost.
Copyright © 2012 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22682085     DOI: 10.1016/j.clnu.2012.05.011

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  35 in total

1.  Use of 14C-glucose by primary cultures of mature rat epididymal adipocytes. Marked release of lactate and glycerol, but limited lipogenesis in the absence of external stimuli.

Authors:  Ana Cecilia Ho-Palma; Floriana Rotondo; María Del Mar Romero; José Antonio Fernández-López; Xavier Remesar; Marià Alemany
Journal:  Adipocyte       Date:  2018-04-30       Impact factor: 4.534

2.  Editorial: is it time for an evolutionarily based human endocrinology?

Authors:  Peter S Rotwein
Journal:  Mol Endocrinol       Date:  2015-04

3.  Effects of a physical and energetic challenge on male California mice (Peromyscus californicus): modulation by reproductive condition.

Authors:  Meng Zhao; Theodore Garland; Mark A Chappell; Jacob R Andrew; Breanna N Harris; Wendy Saltzman
Journal:  J Exp Biol       Date:  2018-01-11       Impact factor: 3.312

Review 4.  The good, the bad, and the ugly facets of insulin resistance.

Authors:  K V S Hari Kumar
Journal:  Med J Armed Forces India       Date:  2020-01-06

Review 5.  Endothelial dysfunction in (pre)diabetes: characteristics, causative mechanisms and pathogenic role in type 2 diabetes.

Authors:  Etto C Eringa; Erik H Serne; Rick I Meijer; Casper G Schalkwijk; Alfons J H M Houben; Coen D A Stehouwer; Yvo M Smulders; Victor W M van Hinsbergh
Journal:  Rev Endocr Metab Disord       Date:  2013-03       Impact factor: 6.514

6.  The growing prevalence of type 2 diabetes: increased incidence or improved survival?

Authors:  Nisa M Maruthur
Journal:  Curr Diab Rep       Date:  2013-12       Impact factor: 4.810

Review 7.  Updates in Glycemic Management in the Hospital.

Authors:  Wasineenart Mongkolpun; Bruna Provenzano; Jean-Charles Preiser
Journal:  Curr Diab Rep       Date:  2019-11-20       Impact factor: 4.810

Review 8.  Could Intermittent Energy Restriction and Intermittent Fasting Reduce Rates of Cancer in Obese, Overweight, and Normal-Weight Subjects? A Summary of Evidence.

Authors:  Michelle N Harvie; Tony Howell
Journal:  Adv Nutr       Date:  2016-07-15       Impact factor: 8.701

9.  Monitoring the Impact of Aggressive Glycemic Intervention during Critical Care after Cardiac Surgery with a Glycemic Expert System for Nurse-Implemented Euglycemia: The MAGIC GENIE Project.

Authors:  R Harsha Rao; Peter L Perreiah; Candace A Cunningham
Journal:  J Diabetes Sci Technol       Date:  2021-03

Review 10.  The role of ectopic adipose tissue: benefit or deleterious overflow?

Authors:  Toon J I De Munck; Peter B Soeters; Ger H Koek
Journal:  Eur J Clin Nutr       Date:  2020-08-14       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.